INTERNATIONAL PATENT: PROQR THERAPEUTICS II B.V. FILES APPLICATION FOR "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF FATTY LIVER DISEASE"

GENEVA, Nov. 3 -- PROQR THERAPEUTICS II B.V. (Zernikedreef 92333 CK Leiden) filed a patent application (PCT/EP2025/061190) for "ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF FATTY LIVER DISEASE" on Apr 24, 2025. With publication no. WO/2025/224230, the details related to the patent application was published on Oct 30, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): POTMAN, Marko (ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden), KLEIN, Bart (ProQR Therapeutics II B.V.Zernikedreef 92333 CK Leiden), HELVENSTEIJN, Werner (ProQR Therapeutics II B.VZernikedreef 92333 CK Leiden)

Abstract...